Cargando…

Adult neurogenic deficits in HIV-1 Tg26 transgenic mice

BACKGROUND: Even in the antiretroviral treatment (ART) era, HIV-1-infected patients suffer from milder forms of HIV-1-associated neurocognitive disorders (HAND). While the viral proteins Tat and gp120 have been shown to individually inhibit the proliferation and neural differentiation of neural stem...

Descripción completa

Detalles Bibliográficos
Autores principales: Putatunda, Raj, Zhang, Yonggang, Li, Fang, Yang, Xiao-Feng, Barbe, Mary F, Hu, Wenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182864/
https://www.ncbi.nlm.nih.gov/pubmed/30314515
http://dx.doi.org/10.1186/s12974-018-1322-2
_version_ 1783362660070326272
author Putatunda, Raj
Zhang, Yonggang
Li, Fang
Yang, Xiao-Feng
Barbe, Mary F
Hu, Wenhui
author_facet Putatunda, Raj
Zhang, Yonggang
Li, Fang
Yang, Xiao-Feng
Barbe, Mary F
Hu, Wenhui
author_sort Putatunda, Raj
collection PubMed
description BACKGROUND: Even in the antiretroviral treatment (ART) era, HIV-1-infected patients suffer from milder forms of HIV-1-associated neurocognitive disorders (HAND). While the viral proteins Tat and gp120 have been shown to individually inhibit the proliferation and neural differentiation of neural stem cells (NSCs), no studies have characterized the effects of all the combined viral proteins on adult neurogenesis. METHODS: The HIV-1 Tg26 transgenic mouse model was used due to its clinical relevance to ART-controlled HIV-1-infected patients who lack active viral replication but suffer from continuous stress from the viral proteins. Quantitative RT-PCR analysis was performed to validate the expression of viral genes in the neurogenic zones. In vitro stemness and lineage differentiation assays were performed in cultured NSCs from HIV-1 Tg26 transgenic mice and their wild-type littermates. Hippocampal neurogenic lineage analysis was performed to determine potential changes in initial and late differentiation of NSCs in the subgranular zone (SGZ). Finally, fluorescent retroviral labeling of mature dentate granule neurons was performed to assess dendritic complexity and dendritic spine densities. RESULTS: Varying copy numbers of partial gag (p17), tat (unspliced and spliced variants), env (gp120), vpu, and nef transcripts were detected in the neurogenic zones of Tg26 mice. Significantly fewer primary neurospheres and a higher percentage of larger sized primary neurospheres were generated from Tg26 NSCs than from littermated wild-type mouse NSCs, implying that Tg26 mouse NSCs exhibit deficits in initial differentiation. In vitro differentiation assays revealed that Tg26 mouse NSCs have reduced neuronal differentiation and increased astrocytic differentiation. In the SGZs of Tg26 mice, significantly higher amounts of quiescent NSCs, as well as significantly lower levels of active NSCs, proliferating neural progenitor cells, and neuroblasts, were observed. Finally, newborn mature granule neurons in the dentate gyri of Tg26 mice had deficiencies in dendritic arborization, dendritic length, and dendritic spine density. CONCLUSIONS: Both in vitro and in vivo studies demonstrate that HIV-1 Tg26 mice have early- and late-stage neurogenesis deficits, which could possibly contribute to the progression of HAND. Future therapies should be targeting this process to ameliorate, if not eliminate HAND-like symptoms in HIV-1-infected patients.
format Online
Article
Text
id pubmed-6182864
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61828642018-10-18 Adult neurogenic deficits in HIV-1 Tg26 transgenic mice Putatunda, Raj Zhang, Yonggang Li, Fang Yang, Xiao-Feng Barbe, Mary F Hu, Wenhui J Neuroinflammation Research BACKGROUND: Even in the antiretroviral treatment (ART) era, HIV-1-infected patients suffer from milder forms of HIV-1-associated neurocognitive disorders (HAND). While the viral proteins Tat and gp120 have been shown to individually inhibit the proliferation and neural differentiation of neural stem cells (NSCs), no studies have characterized the effects of all the combined viral proteins on adult neurogenesis. METHODS: The HIV-1 Tg26 transgenic mouse model was used due to its clinical relevance to ART-controlled HIV-1-infected patients who lack active viral replication but suffer from continuous stress from the viral proteins. Quantitative RT-PCR analysis was performed to validate the expression of viral genes in the neurogenic zones. In vitro stemness and lineage differentiation assays were performed in cultured NSCs from HIV-1 Tg26 transgenic mice and their wild-type littermates. Hippocampal neurogenic lineage analysis was performed to determine potential changes in initial and late differentiation of NSCs in the subgranular zone (SGZ). Finally, fluorescent retroviral labeling of mature dentate granule neurons was performed to assess dendritic complexity and dendritic spine densities. RESULTS: Varying copy numbers of partial gag (p17), tat (unspliced and spliced variants), env (gp120), vpu, and nef transcripts were detected in the neurogenic zones of Tg26 mice. Significantly fewer primary neurospheres and a higher percentage of larger sized primary neurospheres were generated from Tg26 NSCs than from littermated wild-type mouse NSCs, implying that Tg26 mouse NSCs exhibit deficits in initial differentiation. In vitro differentiation assays revealed that Tg26 mouse NSCs have reduced neuronal differentiation and increased astrocytic differentiation. In the SGZs of Tg26 mice, significantly higher amounts of quiescent NSCs, as well as significantly lower levels of active NSCs, proliferating neural progenitor cells, and neuroblasts, were observed. Finally, newborn mature granule neurons in the dentate gyri of Tg26 mice had deficiencies in dendritic arborization, dendritic length, and dendritic spine density. CONCLUSIONS: Both in vitro and in vivo studies demonstrate that HIV-1 Tg26 mice have early- and late-stage neurogenesis deficits, which could possibly contribute to the progression of HAND. Future therapies should be targeting this process to ameliorate, if not eliminate HAND-like symptoms in HIV-1-infected patients. BioMed Central 2018-10-12 /pmc/articles/PMC6182864/ /pubmed/30314515 http://dx.doi.org/10.1186/s12974-018-1322-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Putatunda, Raj
Zhang, Yonggang
Li, Fang
Yang, Xiao-Feng
Barbe, Mary F
Hu, Wenhui
Adult neurogenic deficits in HIV-1 Tg26 transgenic mice
title Adult neurogenic deficits in HIV-1 Tg26 transgenic mice
title_full Adult neurogenic deficits in HIV-1 Tg26 transgenic mice
title_fullStr Adult neurogenic deficits in HIV-1 Tg26 transgenic mice
title_full_unstemmed Adult neurogenic deficits in HIV-1 Tg26 transgenic mice
title_short Adult neurogenic deficits in HIV-1 Tg26 transgenic mice
title_sort adult neurogenic deficits in hiv-1 tg26 transgenic mice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182864/
https://www.ncbi.nlm.nih.gov/pubmed/30314515
http://dx.doi.org/10.1186/s12974-018-1322-2
work_keys_str_mv AT putatundaraj adultneurogenicdeficitsinhiv1tg26transgenicmice
AT zhangyonggang adultneurogenicdeficitsinhiv1tg26transgenicmice
AT lifang adultneurogenicdeficitsinhiv1tg26transgenicmice
AT yangxiaofeng adultneurogenicdeficitsinhiv1tg26transgenicmice
AT barbemaryf adultneurogenicdeficitsinhiv1tg26transgenicmice
AT huwenhui adultneurogenicdeficitsinhiv1tg26transgenicmice